Designing modular, automated vial fill-finish lines that balance high-output demands with small-batch precision in an Annex 1 ...

Advances in instrumentation, modeling and control are more fully understood and utilized when assisted by first-principle, ...

A cube of healthy bone is anything but solid. Inside it, countless tiny channels carry fluid and help cells move, feed, and ...

Once the active ingredient is defined, an Applicant must select which patent, or patents, to put forward for extension. The statute permits only one PTE per regulatory review period, so the choice is ...

Treating brain diseases like tumors and Alzheimer's is notoriously difficult due to the blood-brain barrier (BBB), which blocks most drugs. While nanomedicine offers a promising solution, its path to ...

Discover the transformation of antibody-drug conjugates (ADCs) from experimental to essential in cancer therapy with new ...

Pfizer (NYSE:PFE) and Astellas Pharma reported positive pivotal Phase 3 results for PADCEV plus Keytruda in muscle invasive bladder cancer. The EV-304 (KEYNOTE-B15) trial showed a substantial ...

AbbVie Inc. (NYSE:ABBV), included in the Russell 1000, remains a prominent name across widely followed market indices. Recent ...

Editor’s note: This round‑up is based on press releases, peer‑reviewed publications, and company communications received in January and February 2026. All results are preliminary unless stated, and ...

Key opportunities in the targeted drug delivery market include advances in precision medicine, next-gen carrier tech, strategic partnerships, resilient supply chains, and patient-centric design.

Virginia attracted $12 billion in pharmaceutical manufacturing investments in 2025, leveraging site readiness, workforce training, and strong infrastructure.

People Science today announced the publication of a randomized, double-blind, placebo-controlled clinical trial conducted with Mimio Health in Nature Scientific Reports, marking an important step ...